What does NZYM mean in NASDAQ SYMBOLS
SYNTHETECH, Inc. (NZYM) is a publicly-traded healthcare and life sciences company that specializes in providing products and services for the pharmaceutical, medical device, biotechnology, nutrition industries, and more. NZYM's portfolio includes research and development of innovative products and technology platforms to meet the challenges of today's global healthcare environment.
NZYM meaning in NASDAQ Symbols in Business
NZYM mostly used in an acronym NASDAQ Symbols in Category Business that means Synthetech, Inc.
Shorthand: NZYM,
Full Form: Synthetech, Inc.
For more information of "Synthetech, Inc.", see the section below.
Essential Questions and Answers on Synthetech, Inc. in "BUSINESS»NASDAQ"
What type of company is NZYM?
NZYM is a publicly-traded healthcare and life sciences company that specializes in providing products and services for the pharmaceutical, medical device, biotechnology, nutrition industries, and more.
What specific services does NZYM provide?
NZYM offers research and development of innovative products and technology platforms to meet the challenges of today's global healthcare environment.
How much experience does NZYM have?
SYNTHETECH has been operating for over 20 years with a strong commitment to innovation. The team has extensive experience developing new products for leading healthcare companies around the world.
What are some of the achievements of NZYM?
In recent years, SYNTHETECH has achieved several milestones such as delivering successful outcomes in clinical trials for its new diabetes therapy product line, launching several nutritional supplements with leading retail partners in Europe and creating an advanced data analytics platform to improve patient outcomes.
Is there opportunity to invest with NZYM?
Yes! Currently investors can purchase shares of SYNTHETECH through online brokers or through their local financial institution (i.e., banks).
Final Words:
SYNTHETECH is an established leader in providing innovative products and services for the global healthcare industry. With over 20 years' experience in product innovation, clinical trial successes, strategic partnerships with leading retailers in Europe, advanced analytics platforms - investors have plenty of opportunities to benefit from investing with them!